BioTissue Ocular

It was a privilege to support Eyeprentice and be part of the conversations shaping the future of ophthalmology. We appreciated the opportunity to showcase CAM360 AmnioGraft™ and Prokera® while connecting with both experienced physicians and emerging leaders in the field.

Thank you to everyone who shared their insights, experiences, and passion for advancing patient care.

Most patients don't present with just one concern.

Dry eye symptoms, corneal staining, and reduced corneal sensitivity can all be part of the same clinical picture. CAM360 AmnioGraft™ was developed to support the ocular surface.

Explore CAM360 AG on our website!



1. McDonald, M, Janik, SB, Bowden, FW. et al. Association of Treatment Duration and Clinical Outcomes in Dry Eye Treatment with Sutureless Cryopreserved Amniotic Membrane. Clin Ophthalmol. 2023;Sep 12:17:2697- 2703. https://doi.org/10.2147/opth.s423040

2. John, T, Tighe, S, Sheha, H. et al. Corneal Nerve Regeneration after Self-Retained Cryopreserved Amniotic Membrane in Dry Eye Disease. J Ophthalmol. 2017;2017:6404918. https://doi.org/10.1155/2017/6404918

3. Stevanovic M, Ciarmiello G, Eden R, Schultze R. Therapeutic Outcomes of Shelf-Stable, Cryopreserved Amniotic Membrane in Recalcitrant Keratopathy. Clin Ophthalmol. 2025 Dec 9;19:4545-4550.

Today, on World Sjögren's Day, we join the global community in raising awareness of this debilitating autoimmune disease that can significantly impact ocular surface health.¹

For many patients, chronic dry eye is one of the earliest and most common manifestations of the disease, affecting comfort, vision, and quality of life.¹

Cryopreserved amniotic membrane (CAM) has been shown to support ocular surface healing by reducing inflammation and supporting restoration of corneal nerves.²

At BioTissue®, we are committed to advancing awareness of ocular surface disease and supporting eye care professionals in helping patients achieve better outcomes.

1. Roszkowska AM, Oliverio GW, Aragona E, Inferrera L, Severo AA, Alessandrello F, Spinella R, Postorino EI, Aragona P. Manifestations of Primary Sjögren's Syndrome. Genes (Basel). 2021;12(3):365.

2. John T, Tighe S, Sheha H, et al. Corneal Nerve Regeneration after Self-Retained Cryopreserved Amniotic Membrane in Dry Eye Disease. J Ophthalmol. 2017;2017:6404918.

This Dry Eye Awareness Month, remember that not every patient who looks like they have Dry Eye has only Dry Eye.

Recognizing the warning signs early may provide an opportunity to identify Neurotrophic Keratitis before the disease progresses to persistent epithelial defect (PED) or corneal ulcers.

At the heart of every great meeting is a community committed to advancing patient care.

Thank you to everyone who connected with us at AECOS Summer. We're honored to support physicians with solutions across ocular care and excited for what's ahead.

While the world watches the World Cup, we're raising awareness of Neurotrophic Keratitis.

This Dry Eye Awareness Month, remember that Neurotrophic Keratitis can present similarly to Dry Eye disease.¹



1. Stolz M. The Prevalence of Corneal Sensitivity Loss in Patients with and without Dry Eye Disease. Clin Ophthalmol. 2025 Apr 18;19:1323-1330.

We're headed to AECOS Summer! ☀️

Stop by and connect with our team to learn how CAM360 AmnioGraft™, Prokera®, AmnioGraft®, and AmnioGuard® are helping support patient outcomes.

See you in Utah!

Wishing you a safe & joyful 4th of July!